stars 1 stars 2 stars 3

BIOLYPH has the production processes to convert manufacturers’ unstable reagents into stable LyoSpheres™ and the disposable devices to deliver rehydrated lyophilized reagents. LyoSpheres™ are microliter aliquots of reagents that are lyophilized as precise and durable spheres and packaged inside most delivery devices. This capability allows incompatible reagents to coexist compatibly in a shelf-stable environment while awaiting rehydration. BIOLYPH has also developed a line of Lyophilized Reagent Delivery Systems named ReActivator™. ReActivator™ incorporates manufacturers’ preportioned lyophilized reagents and diluents together inside an easy-to-use, disposable, unit-of-use rehydrating dispenser providing your customers with convenient, precise, contaminant-free reagents.

BIOLYPH Questions

The BIOLYPH annual revenue was $9 million in 2026.

Timothy Pearcy is the Founder, Managing Director and Governor of BIOLYPH.

29 people are employed at BIOLYPH.

BIOLYPH is based in Chaska, Minnesota.

The NAICS codes for BIOLYPH are [54, 5417, 54171, 541, 541713].

The SIC codes for BIOLYPH are [87, 873].

Top BIOLYPH Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users